The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated safety and efficacy results from the phase I study of either LBL-007 (an anti-LAG-3 antibody) in combination with toripalimab (an anti-PD-1 antibody) or LBL-007 in combination with toripalimab and axitinib in patients with advanced melanoma.
 
Xue Bai
No Relationships to Disclose
 
Mei Li
No Relationships to Disclose
 
Yu Chen
No Relationships to Disclose
 
Lu Si
Honoraria - MSD; Novartis; Oriengene; Roche China; Shanghai Junshi Biosciences
 
Jing Chen
No Relationships to Disclose
 
Xingxiang Pu
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose
 
Zhengyun Zou
No Relationships to Disclose
 
Shiwei Zhao
Employment - Leads Biolabs
Honoraria - Leads Biolabs
Travel, Accommodations, Expenses - Leads Biolabs
 
Tao Li
Employment - Leads Biolabs
Honoraria - Leads Biolabs
Travel, Accommodations, Expenses - Leads Biolabs
 
Shengli Cai
Employment - Leads Biolabs
Leadership - Leads Biolabs
Honoraria - Leads Biolabs
Travel, Accommodations, Expenses - Leads Biolabs
 
Jun Guo
No Relationships to Disclose